Home Versus Office Removal of Percutaneous Nerve Evaluation (PNE) Lead
Launched by THE CLEVELAND CLINIC · Mar 23, 2023
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how women feel about removing a device called a PNE lead, which is used to help treat overactive bladder. The study compares two ways to remove this lead: some women will take it out at home, while others will have it removed in a doctor's office. The researchers want to find out if there is a difference in satisfaction between these two methods.
To participate in this trial, women must be at least 18 years old and are planning to undergo a specific therapy for bladder issues. However, those who have had previous treatments, cannot understand English well, or do not have someone at home to help them with the lead removal won't be eligible. If you join the study, you can expect to share your experience and feelings about the lead removal process, whether done at home or in the office. This information will help improve care for women dealing with overactive bladder in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age greater than or equal to 18 years of age
- • Patients undergoing sacral neuromodulation (SNM) for urinary urgency incontinence or urgency-frequency syndrome
- Exclusion Criteria:
- • Inability to comprehend written and/or spoken English
- • Inability to provide informed consent
- • Patients undergoing SNM for other indications (e.g. urinary retention, fecal incontinence,)
- • Previous SNM treatment
- • No home support to assist with lead removal
About The Cleveland Clinic
The Cleveland Clinic is a renowned nonprofit academic medical center based in Cleveland, Ohio, recognized for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, the Cleveland Clinic leverages its multidisciplinary expertise and state-of-the-art facilities to conduct groundbreaking studies aimed at improving patient outcomes across a wide range of medical conditions. With a strong emphasis on patient-centered care, the institution fosters collaboration among researchers, clinicians, and patients to explore new treatments and therapies, contributing significantly to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cleveland, Ohio, United States
Patients applied
Trial Officials
Cecile A. Ferrando, M.D.
Principal Investigator
The Cleveland Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials